DREN uses an advanced pharmacological approach to trigger the process of lipolysis for maximum fat burning. DREN ( patent pending compound name DRENBUTEROL) belongs to a powerful new class of compounds called mesolimbic Beta Agonist Fat Burning Agents. Its mechanism of action is similar to that of the popular old ECA (ephedra, caffeine, and aspirin) stack, but even more parallel to those of Clenbuterol. Like Clenbuterol, DREN poses more selective and powerful beta-adrenergic fat burning activity then ephedra. Plus in addition to extreme thermogenic effects, DREN also has powerful psycho-active euphoric effects.
Bookmarks